Strum Jay

CIK 00017068511 companyRESEARCH TRIANGLE PARK, NC

SEC Profile

Transactions

Companies

Filings

CIK

0001706851

Recent Transactions

19 trades

Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2019-01-02$0.30/sh+39,485→ 88,904 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-01-02−13,333→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-01-02−27,000→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-01-02−13,333→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-01-02−15,816→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-01-02−10,336→ 0 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2019-01-02$0.39/sh+40,333→ 129,237 total
Award
G1 Therapeutics, Inc.
Stock Option (Right to Buy)
2019-01-02+15,000→ 15,000 total
Exercise/Conversion
G1 Therapeutics, Inc.
Common Stock
2018-10-04$0.30/sh+850→ 49,419 total
Exercise/Conversion
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-10-04−850→ 15,816 total
Sale
G1 Therapeutics, Inc.
Comomon Stock
2018-08-30$60.05/sh−4,500→ 48,569 total
Sale
G1 Therapeutics, Inc.
Comomon Stock
2018-08-30$59.27/sh−500→ 53,069 total
Sale
G1 Therapeutics, Inc.
Comomon Stock
2018-08-29$59.10/sh−3,500→ 54,469 total
Sale
G1 Therapeutics, Inc.
Comomon Stock
2018-08-29$61.00/sh−200→ 53,569 total
Sale
G1 Therapeutics, Inc.
Comomon Stock
2018-08-29$58.40/sh−600→ 57,969 total
Sale
G1 Therapeutics, Inc.
Comomon Stock
2018-08-29$60.00/sh−700→ 53,769 total
Award
G1 Therapeutics, Inc.
Stock Options (Right to Buy)
2018-01-02+25,000→ 25,000 total
Conversion
G1 Therapeutics, Inc.
Common Stock
2017-05-22+16,666→ 58,569 total
Conversion
G1 Therapeutics, Inc.
Series 1 Preferred
2017-05-22−50,000→ 0 total

Companies

G1 Therapeutics, Inc.
Chief Scientific Officer

Recent Filings

Address

C/O G1 THERAPEUTICS, INC. 79 T.W. ALEXANDER DRIVE

RESEARCH TRIANGLE PARK, NC, 27709

View on SEC.gov